8 analysts have shared their evaluations of Health Catalyst (NASDAQ:HCAT) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table encapsulates their ...

Providing a diverse range of perspectives from bullish to bearish, 10 analysts have published ratings on Health Catalyst (NASDAQ:HCAT) in the last three months. In the table below, you'll find a ...

The latest price target for Health Catalyst (NASDAQ:HCAT) was reported by Citigroup on November 11, 2025. The analyst firm set a price target for $3.25 expecting HCAT to rise to within 12 months (a ...

Throughout the last three months, 4 analysts have evaluated Health Catalyst (NASDAQ:HCAT), offering a diverse set of opinions from bullish to bearish. The table below summarizes their recent ratings, ...

Health Catalyst’s third quarter results were met with a positive market reaction as the company delivered revenue above Wall Street expectations despite flat year-over-year performance. Management ...